As of 2026-03-23, the Relative Valuation of Talaris Therapeutics Inc (TALS) is (35.81) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.72 USD, the upside of Talaris Therapeutics Inc based on Relative Valuation is -1416.4%.
The range of the Relative Valuation is (35.35) - (37.10) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 20.2x - 22.8x | 20.6x |
| Forward P/E multiples | 19.3x - 21.2x | 20.4x |
| Fair Price | (35.35) - (37.10) | (35.81) |
| Upside | -1399.7% - -1463.9% | -1416.4% |
| Date | P/E |